Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immunotherapy
Page 1 of 5 ( 222 items )
<<
1
2
3
4
5
>>
1
Prognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection
7/14/2025 12:56:06 PM |
Browse: 42 |
Download: 186
2
Programmed cell death 1 inhibitor sintilimab plus S-1 and gemcitabine for liver metastatic pancreatic ductal adenocarcinoma
12/11/2024 10:19:43 AM |
Browse: 76 |
Download: 503
3
Immunotherapy for metastatic gastric cancer
10/30/2024 2:58:47 PM |
Browse: 95 |
Download: 442
4
Impact of liver metastasis on immunotherapy in gastric carcinoma
9/28/2024 4:34:19 AM |
Browse: 108 |
Download: 433
5
Immunotherapy for gastric cancer and liver metastasis: Is it time to bid farewell
8/16/2024 3:30:03 PM |
Browse: 142 |
Download: 518
6
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
8/16/2024 8:03:14 AM |
Browse: 170 |
Download: 473
7
Impact of immunotherapy on liver metastasis
7/22/2024 11:57:17 AM |
Browse: 151 |
Download: 427
8
Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma
7/16/2024 6:17:55 AM |
Browse: 157 |
Download: 561
9
Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies
6/25/2024 10:41:21 AM |
Browse: 133 |
Download: 489
10
Comparative effectiveness of immunotherapy and chemotherapy in patients with metastatic colorectal cancer stratified by microsatellite instability status
4/22/2024 9:51:56 AM |
Browse: 161 |
Download: 624
11
Immune checkpoint inhibitor-associated gastritis: Patterns and management
4/12/2024 4:45:44 PM |
Browse: 186 |
Download: 674
12
Approaches and challenges in cancer immunotherapy pathways
3/22/2024 11:48:13 AM |
Browse: 178 |
Download: 614
13
Revolutionizing gastric cancer treatment: The potential of immunotherapy
1/26/2024 7:56:28 AM |
Browse: 299 |
Download: 787
14
Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
10/27/2023 3:28:49 PM |
Browse: 349 |
Download: 1370
15
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
7/10/2023 8:58:21 AM |
Browse: 340 |
Download: 1007
16
Immunotherapy for advanced gastric cancer
6/20/2023 11:28:13 AM |
Browse: 368 |
Download: 970
17
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
6/12/2023 8:16:26 AM |
Browse: 324 |
Download: 873
18
Immunotherapy for recurrent hepatocellular carcinoma
4/14/2023 1:45:13 PM |
Browse: 361 |
Download: 911
19
“Cold” colorectal cancer faces a Bottleneck in immunotherapy
2/15/2023 12:44:08 AM |
Browse: 390 |
Download: 949
20
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature
11/23/2022 9:44:45 AM |
Browse: 388 |
Download: 1356
21
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
11/21/2022 4:25:35 AM |
Browse: 503 |
Download: 1109
22
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
11/17/2022 4:40:53 AM |
Browse: 608 |
Download: 1412
23
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
11/10/2022 9:21:28 AM |
Browse: 485 |
Download: 1434
24
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
10/27/2022 4:55:05 AM |
Browse: 466 |
Download: 1180
25
Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
10/27/2022 4:55:05 AM |
Browse: 562 |
Download: 1421
26
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
10/27/2022 3:05:58 AM |
Browse: 426 |
Download: 1487
27
Longest survival with primary intracranial malignant melanoma: A case report and literature review
10/21/2022 2:24:59 AM |
Browse: 486 |
Download: 1230
28
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
10/21/2022 2:24:59 AM |
Browse: 462 |
Download: 1179
29
Autoimmune encephalitis with posterior reversible encephalopathy syndrome: A case report
10/21/2022 2:24:59 AM |
Browse: 458 |
Download: 1159
30
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
10/14/2022 12:54:50 PM |
Browse: 567 |
Download: 2121
31
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
10/14/2022 8:30:45 AM |
Browse: 492 |
Download: 1235
32
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM |
Browse: 498 |
Download: 1195
33
Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report
9/27/2022 1:00:18 PM |
Browse: 912 |
Download: 1358
34
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
9/23/2022 10:13:16 AM |
Browse: 542 |
Download: 1381
35
Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
9/22/2022 6:32:13 AM |
Browse: 451 |
Download: 1129
36
Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report
9/16/2022 11:52:44 AM |
Browse: 482 |
Download: 1240
37
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 493 |
Download: 1744
38
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 498 |
Download: 1482
39
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM |
Browse: 505 |
Download: 1237
40
Advances in postoperative adjuvant therapy for primary liver cancer
9/9/2022 12:48:14 PM |
Browse: 550 |
Download: 1573
41
Treatment of gastric carcinoma with lymphoid stroma by immunotherapy: A case report
8/26/2022 9:54:53 AM |
Browse: 524 |
Download: 1606
42
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
8/26/2022 9:51:35 AM |
Browse: 453 |
Download: 1172
43
Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report
8/16/2022 1:35:32 AM |
Browse: 405 |
Download: 1261
44
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 555 |
Download: 1476
45
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
7/27/2022 2:48:53 AM |
Browse: 549 |
Download: 1187
46
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
7/27/2022 2:48:53 AM |
Browse: 486 |
Download: 1015
47
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
7/22/2022 9:38:18 AM |
Browse: 597 |
Download: 1430
48
Nanomedicine approaches for treatment of hematologic and oncologic malignancies
7/22/2022 9:38:18 AM |
Browse: 552 |
Download: 1321
49
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
7/18/2022 9:47:46 AM |
Browse: 670 |
Download: 1303
50
Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report
7/11/2022 8:36:01 AM |
Browse: 452 |
Download: 1431
Page 1 of 5 ( 222 items )
<<
1
2
3
4
5
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345